ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

462
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
08 Apr 2020 07:10

Big Short Covering on Celltrion Inc & Celltrion Healthcare

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 3 April 2020, the...

Logo
379 Views
Share
07 Apr 2020 03:45

Celltrion Healthcare Block Deals: Conditions, Discount, Overhang, & Arb Yield

It is now clear that neither OEP or Ion (Temasek) wants to stay at Celltrion as a long-term investor. Celltrion management reportedly asked OEP...

Logo
363 Views
Share
06 Apr 2020 19:19

Another Block Deal for Celltrion Healthcare

After the market close today, Celltrion Healthcare (091990 KS) announced that there will be a block deal worth about 272 billion won ($221 million)...

Logo
319 Views
Share
04 Apr 2020 08:20

Celltrion Pairs Trading Dynamics Checkup: Healthcare at a 2-Yr High

The Celltrion pair (Celltrion and Celltrion Healthcare) is another one ideally matched for pairs trading. As shown below, they are highly...

Logo
323 Views
Share
bullishCelltrion Inc
03 Apr 2020 13:52

More Celltrion Block Deals from Temasek Soon? It Seems So

Should we expect more block deals from Temasek? It seems that we should. It seems more evident now that Temasek isn't planning to stay at Celltrion...

Logo
353 Views
Share
x